Microbot Medical 提交8-K，宣布5月18日舉行投資者電話會議

false
 0000883975
 
 
 
 
 
 
 
 0000883975
 
 
 2026-05-15
 2026-05-15
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 

 

 

 

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549

 

FORM
8-K

 

CURRENT
REPORT

Pursuant
to Section 13 or 15(d)

of
the Securities Exchange Act of 1934

 

Date
of Report (Date of earliest event reported): May 15, 2026

 

MICROBOT
MEDICAL INC.

(Exact
name of registrant as specified in its charter)

 

 
 Delaware
  
 000-19871
  
 94-3078125

 
 (State
 or other jurisdiction

 of
 incorporation)

  
 (Commission

 File
 Number)

  
 (IRS
 Employer

 Identification
 No.)

 
 

175
Derby St., Bld. 27

Hingham,
MA 02043

(Address
of Principal Executive Offices) (Zip Code)

 

Registrant’s
telephone number, including area code: (781) 875-3605

 

 

(Former
Name or Former Address, if Changed Since Last Report)

 

Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:

 

 
 ☐
 Written communications
 pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
  
  

 
 ☐
 Soliciting material pursuant
 to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
  
  

 
 ☐
 Pre-commencement communications
 pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
  
  

 
 ☐
 Pre-commencement communications
 pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

Securities
registered pursuant to Section 12(b) of the Act:

 

 
 Title
 of each class
  
 Trading
 Symbol(s)
  
 Name
 of each exchange on which registered

 
 Common Stock, $0.01 par
 value
  
 MBOT
  
 NASDAQ Capital Market

 
 

Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging
Growth Company ☐

 

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

  

  

 

 

Item
7.01 Regulation FD Disclosure.

 

On
May 15, 2026, Microbot Medical Inc. issued a press release announcing that it will be hosting an analysts and investors conference call
and live webcast on Monday, May 18th, at 3:00pm ET.

 

To
access the live webcast of the conference call, please go to the investor relations section of Microbot Medical’s website at http://www.microbotmedical.com.
Participants may also register via teleconference at: https://register-conf.media-server.com/register/BI3230e15aa058488caa9b629910cade7c.
Once registration is completed, participants will be provided with a dial-in number containing a personalized PIN to access the call.
Participants are requested to register a day in advance or at a minimum 15 minutes before the start of the call.

 

The
press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K, is incorporated herein by reference. The information
in this Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed to be “filed” for the purposes of Section 18
of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be
deemed an admission as to the materiality of any information in this Item 7.01 or Exhibit 99.1.

 

Item
9.01. Financial Statements and Exhibits.

 

(d)
Exhibits

 

 
 Exhibit

 Number
  
 Description

 
  
  
  

 
 99.1
  
 Press Release

 
 104
  
 Cover
 Page Interactive Data File (embedded within the Inline XBRL document)

 
 

  

  

 

 

SIGNATURES

 

Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

 

 
  
 MICROBOT MEDICAL INC.

 
  
  

 
  
 By:
 /s/
 Harel Gadot

 
  
 Name:
 Harel Gadot

 
  
 Title:
 Chief Executive Officer, President and Chairman

 
 

Date:
May 15, 2026